Skip to content Norwegian Medical Products Agency Norwegian Medical Products Agency

Guideline for submission of documentation for single technology assessments

Published:

|

Updated:

Changes

  • : Updated guideline for submission and procession requirements.
  • : The guidelines are updated with a text regarding the use of AI in submission dossiers
  • : Updated submission guidelines
  • : Revised guidelines

HTDs must use the submission guideline when preparing and submitting documentation for single technology assessments, both for decisions regarding public reimbursement (“Blåresept”) and funding by the Regional Health Authorities ("Nye metoder").

The submission guideline was last revised on July 6, 2026.

Submission guideline (PDF)

 

To avoid delays in the assessment, HTDs are encouraged to use our submission template when preparing documentation. 

Must- and should requirements in effect as of July 2026

NOMA has updated its submission guideline for single technology assessments. Our template for submission of documentation has been revised to align with these changes. The new guideline is in effect from July 6, 2026.

In the new version, we clarify our “must” and “should” requirements for submissions. If the “must” requirements are not met, the documentation will be deemed "not received," and we will not commence the assessment. If the “should” requirements are not met, we will start processing the case, but lacking information may result in a clock-stop.

New Norwegian EQ-5D-5L tariff will be mandatory from September 2025

As of September 1, 2025, it is mandatory to use the Norwegian EQ-5D-5L tariff (Garratt et al., 2024) for documenting health-related quality of life for adults when submitting documentation.

A transition to the new Norwegian EQ-5D-5L tariff also requires the use of updated norm data for age-adjusting utility weights and performing severity calculations. The tool for severity calculations and age adjustment of utility weights is updated with current norm data and available on NOMA’s website.